| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |